Christopher L. D. McMillan

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

Alberto A. Amarilla, Julian D. J. Sng, Rhys Parry et al. · Nature Communications · 2021 · 167 citations · Full text

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran et al. · Molecular Psychiatry · 2022 · 164 citations · Full text

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Adi Idris, Alicia Davis, Aroon Supramaniam et al. · Molecular Therapy · 2021 · 159 citations · Full text

Nanomedicine, Antiviral Therapy, Virology +4

An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2

Alberto A. Amarilla, Naphak Modhiran, Yin Xiang Setoh et al. · Frontiers in Microbiology · 2021 · 67 citations · Full text

Vaccination, Plaque Assay, Diagnostic Virology +13

Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2

Daniel Watterson, Danushka K. Wijesundara, Naphak Modhiran et al. · Clinical & Translational Immunology · 2021 · 61 citations · Full text